Register
Forgot your password?

Indications, criteria, choice of the method of myocardial revascularization: european and russian clinical guidelines data

Authors: Sigaev I.Yu., Keren M.A.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2018-12-2-167-176

For citation: Sigaev I.Yu., Keren M.A. Indications, criteria, choice of the method of myocardial revascularization: european and russian clinical guidelines data. Creative Cardiology. 2018; 12 (2): 167–76 (in Russ.). DOI: 10.24022/1997-3187-2018-12-2-167-176

Received / Accepted:  May 17, 2018 / May 22, 2018

Keywords: ischemic heart disease myocardial revascularization coronary artery bypass grafting percutaneous coronary intervention diabetes mellitus carotid endarterectomy repeated revascularization

Full text:  

 

Abstract

The review presents a modern tactic of surgical management of patients with stable ischemic heart disease in various clinical situations. The article presents some aspects of the european recommendations on myocardial revascularization (2014) and russian indications for myocardial revascularization (russian conciliation document) (2011). The use of clinical recommendations in everyday clinical practice makes it possible to determine the main directions of diagnosis and options for surgical treatment. The issues of risk stratification of myocardial revascularization, informing the patient, the strategy of preoperative diagnostics, the determination of indications for revascularization and the choice of the revascularization method are considered. Particular attention is paid to patients with comorbid conditions (diabetes mellitus, multifocal atherosclerosis). Also, strategies for monitoring and managing patients after myocardial revascularization are shown.

Acknowledgements. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.

References

  1. Bockeria L.A., Gudkova R.G. Cardiovascular surgery – 2010. Diseases and congenital anomalies of system of blood circulation. Moscow; 2011: 80–124 (in Russ.).

  2. ESC / EACTS recommendations on myocardial revascularization 2014. Russian Journal of Cardiology. 2015: 2 (118): 5–81 (in Russ.)

  3. Windecker S., Kolh Ph., Alfonso F., Collet J.-Ph., Cremer J., Falk V. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2014; 35 (37): 2541–619. DOI: 10.1093/eurheartj/ehu278

  4. Indications for myocardial revascularization (Russian conciliation document). Moscow: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of RAMS; 2011 (in Russ.)

  5. Montalescot G., Sechtem U., Achenbach S., Andreotti F., Arden C., Budaj A., Bugiardini R. et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013; 34 (38): 2949–3003.

  6. Hulten E., Villines T.C., Cheezum M.K., Ber- man D.S., Dunning A., Achenbach S. et al. Use- fulness of coronary computed tomography angiography to predict mortality and myocardial infarction among Caucasian, African and East Asian ethnicities (from the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter] Registry). Am. J. Cardiol. 2013; 111 (4): 479–85.

  7. Kolh P., Wijns W., Danchin N., Di Mario C., Falk V., Folliguet T. et al. Guidelines on myocardial revascularization. Eur. J. Cardiothorac. Surg. 2010; 38 (Suppl.): S1–S52.

  8. Wijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2010; 31 (20): 2501–55.

  9. Deb S., Wijeysundera H.C., Ko D.T., Tsubota H., Hill S., Fremes S.E. Coronary artery bypass graft surgery vs.percutaneous interventions in coronary revascularization: a systematic review. JAMA. 2013; 310 (19): 2086–95.

  10. Kolh P., Kurlansky P., Cremer J., Lawton J., Siepe M., Fremes S. Transatlantic Editorial: a comparison between European and North American guidelines on myocardial revascularization. Ann. Thorac. Surg. 2016; 101: 2031–44.

  11. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J. et al. Percutaneous coronary intervention vs. coronaryartery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360 (10): 961–72

  12. Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Stahle E., Colombo A. et al. Coronary artery bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381 (9867): 629–38

  13. Head S.J., Davierwala P.M., Serruys P.W., Redwood S.R., Colombo A., Mack M.J. et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year followup of the SYNTAX trial. Eur. Heart J. 2014; 35 (40): 2821–30. DOI: 10.1093/eurheartj/ehu213

  14. Wu C., Camacho F.T., Zhao S., Wechsler A.S., Culliford A.T., Lahey S.J. et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann. Thorac. Surg. 2013; 95 (4): 1297–305

  15. Kapur A., Hall R.J., Malik I.S., Qureshi A.C., Butts J., de Belder M. et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J. Am. Coll. Cardiol. 2010; 55 (5): 432–40.

  16. Kappetein A.P., Head S.J., Morice M.C., Banning A.P., Serruys P.W., Mohr F.W. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur. J. Cardiothorac Surg. 2013; 43 (5): 1006–13

  17. Farkouh M.E., Domanski M., Sleeper L.A., Siami F.S., Dangas G., Mack M. et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 2012; 367 (25): 2375–84

  18. Aboyans V., Lacroix P. Indications for carotid screening in patients with coronary artery disease. Presse Med. 2009; 38 (6): 977–86

  19. Chaturvedi S., Bruno A., Feasby T., Holloway R., Benavente O. et al. Carotid endarterectomy: an evidence-based review: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2005; 65 (6): 794–801

  20. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in col- laboration with the European Society for Vascular Surgery (ESVS). Eur. Heart J. 2017; 00: 1–60

  21. Tendera M., Boyans V., Bartelink M.L., Baumgartner I., Clement D., Collet J.P. et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32 (22): 2851–906

  22. Boylan M.J., Lytle B.W., Loop F.D., Taylor P.C., Borsh J.A., Goormastic M., Cosgrove D.M. Sur- gical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J. Thorac. Cardiovasc. Surg. 1994; 107: 657–62

  23. Schmitto J.D., Rajab T.K., Cohn L.H. Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft. Curr. Opin. Cardiol. 2010; 25 (6): 609–12

  24. De Bruyne B., Pijls N.H., Kalesan B., Barbato E., Tonino P.A., Piroth Z. et al. Fractional flow reserve-guided PCI vs. medical therapy in stable coronary disease. N. Engl. J. Med. 2012; 367 (11): 991–1001

  25. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., Berman D.S. Comparison of the shortterm survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003; 107 (23): 2900–7

  26. Subramanian S., Sabik J.F., 3rd, Houghtaling P.L., Nowicki E.R., Blackstone E.H., Lytle B.W. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. Ann. Thorac. Surg. 2009; 87 (5): 1392–8; discussion 1400

  27. Sabik J.F,. 3rd, Blackstone E.H., Houghtaling P.L., Walts P.A., Lytle B.W. Is reoperation still a risk factor in coronary artery bypass surgery? Ann. Thorac. Surg. 2005; 80 (5): 1719–27

  28. Yap C.H., Sposato L., Akowuah E., Theodore S., Dinh D.T., Shardey G.C. et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann. Thorac. Surg. 2009; 87 (5): 1386–91

  29. Morrison D.A., Sethi G., Sacks J., Henderson W.G., Grover F., Sedlis S., Esposito R. Investigators of the Department of Veterans Affairs Cooperative Study AWESOME. Percutaneous coronary intervention vs. repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J. Am. Coll. Cardiol. 2002; 40 (11): 1951–4

  30. Morrison D.A., Sethi G., Sacks J., Henderson W., Grover F., Sedlis S., Esposito R. et al. Angina with extremely serious operative mortality E. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J. Am. Coll. Cardiol. 2001; 38 (1): 143–9.

  31. Harskamp R.E., Beijk M.A., Damman P., Kuijt W.J., Woudstra P., Grundeken M.J. et al. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure. J. Cardiovasc. Med. (Hagerstown). 2013; 14 (6): 438–45

  32. Sabik J.F. 3rd, Raza S., Blackstone E.H., Houghtaling P.L., Lytle B.W. Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation. J. Am. Coll. Cardiol. 2013; 61 (3): 302–1

  33. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., Albus C. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 2012; 33: 1635–70

About Authors

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by